下载亿题库APP
联系电话:400-660-1360
请谨慎保管和记忆你的密码,以免泄露和丢失
请谨慎保管和记忆你的密码,以免泄露和丢失
最近,有小伙伴在询问最后阶段,考研英语该如何备考才最有效。最后阶段,我们应该将备考的重点放在复习和了解考试上,多去练习历年真题和模拟试题。下面,帮考网为大家带来考研初试的一些模拟试题,一起来看看吧。
At 18, Ashanthi DeSilva of suburban Cleveland is a living symbol of one of the great intellectual achievements of the 20th century. Born with an extremely rare and usually fatal disorder that left her without a functioning immune system (the “bubble-boy disease,” named after an earlier victim who was kept alive for years in a sterile plastic tent), she was treated beginning in 1990 with a revolutionary new therapy that sought to correct the defect at its very source, in the genes of her white blood cells. It worked. Although her last gene-therapy treatment was in 1992, she is completely healthy with normal immune function, according to one of the doctors who treated her, W. French Anderson of the University of Southern California. Researchers have long dreamed of treating diseases from hemophilia to cancer by replacing mutant genes with normal ones. And the dreaming may continue for decades more. “There will be a gene-based treatment for essentially every disease,” Anderson says, “within 50 years.”
It\'s not entirely clear why medicine has been so slow to build on Anderson\'s early success. The National Institutes of Health budget office estimates it will spend $432 million on gene-therapy research in 2005, and there is no shortage of promising leads. The therapeutic genes are usually delivered through viruses that don\'t cause human disease. “The virus is sort of like a Trojan horse,” says Ronald Crystal of New York Presbyterian/Weill Cornell Medical College. “The cargo is the gene.”
At the University of Pennsylvania\'s Abramson Cancer Center, immunologist Carl June recently treated HIV patients with a gene intended to help their cells resist the infection. At Cornell University, researchers are pursuing gene-based therapies for Parkinson\'s disease and a rare hereditary disorder that destroys children\'s brain cells. At Stanford University and the Children\'s Hospital of Philadelphia, researchers are trying to figure out how to help patients with hemophilia who today must inject themselves with expensive clotting drugs for life. Animal experiments have shown great promise.
But somehow, things get lost in the translation from laboratory to patient. In human trials of the hemophilia treatment, patients show a response at first, but it fades over time. And the field has still not recovered from the setback it suffered in 1999, when Jesse Gelsinger, an 18-year-old with a rare metabolic disorder, died after receiving an experimental gene therapy at the University of Pennsylvania. Some experts worry that the field will be tarnished further if the next people to benefit are not patients but athletes seeking an edge. This summer, researchers at the Salk Institute in San Diego said they had created a “marathon mouse” by implanting a gene that enhances running ability; already, officials at the World Anti-Doping Agency are preparing to test athletes for signs of “gene doping.” But the principle is the same, whether you\'re trying to help a healthy runner run faster or allow a muscular-dystrophy patient to walk. “Everybody recognizes that gene therapy is a very good idea,” says Crystal. “And eventually it\'s going to work.”
1. The case of Ashanthi Desilva is mentioned in the text to ____________.
[A] show the promise of gene-therapy
[B] give an example of modern treatment for fatal diseases
[C] introduce the achievement of Anderson and his team
[D] explain how gene-based treatment works
2. Anderson‘s early success has ________________.
[A] greatly speeded the development of medicine
[B] brought no immediate progress in the research of gene-therapy
[C] promised a cure to every disease
[D] made him a national hero
3. Which of the following is true according to the text?
[A] Ashanthi needs to receive gene-therapy treatment constantly.
[B] Despite the huge funding, gene researches have shown few promises.
[C] Therapeutic genes are carried by harmless viruses.
[D] Gene-doping is encouraged by world agencies to help athletes get better scores.
4. The word “tarnish” (line 5, paragraph 4) most probably means ____________.
[A] affect
[B] warn
[C] trouble
[D] stain
5. From the text we can see that the author seems ___________.
[A] optimistic
[B] pessimistic
[C] troubled
[D] uncertain
答案:A B C D A
以上就是帮考网为大家带来的全部内容,希望能给大家一些帮助。帮考网提醒:2021年考研正式报名已经开始,在预报名阶段未来得及报名的小伙伴要注意了。另外,小伙伴们如果还有其他关于考研信息的疑问,也可以留言咨询哦。
以前年度的普通研究生入学考试成绩还能查询吗?:以前年度的普通研究生入学考试成绩还能查询吗?以前的考研成绩能查,成绩查询可以登录中国研究生招生信息网,根据自己报考研究生考试的报名号登陆,即可查询以前的考研成绩。
研究生入学考试要考哪几门?:研究生入学考试要考哪几门?(1)初试是每年1月份全国统考,考试科目分为政治(满分100)、外语(满分100)、专业课一(如数学)、专业课二。公共课包含政治、外语、数学,由全国统一命题。专业课由各学校自主命题。有些专业课统一命题进行联考。有的专业不考数学,考由学校命题的两门专业课。(2)复试分为面试和笔试,学校专业不同,科目形式设置会有不同。
普通研究生证书,研究生文凭和硕士学位三者的区别是什么?:普通研究生证书,研究生文凭和硕士学位三者的区别是什么?硕士研究生若是能正常毕业,那么就会颁发“硕士研究生毕业证书”通过所有的科目考试。并完成了课题的研究,可以颁发,硕士学位证书“有”的不一定都有“但是获得了知“学位证书”的一定都具备,毕业证书“有了以上两本证书后”就可以说是完成了硕士研究生的教育“拥有了”硕士研究生文凭。
2020-06-06
2020-06-06
2020-06-06
2020-06-06
2020-06-06
微信扫码关注公众号
获取更多考试热门资料